Related by context. All words. (Click for frequent words.) 63 therapeutic monoclonal antibodies 62 monoclonal antibody therapeutics 62 rxRNA 62 Anticalins R 61 novel immunomodulatory 61 metabonomics 61 anticancer therapeutics 61 Logical Therapeutics 61 Homspera TM 61 Capsulution 61 Liprotamase 60 chimeric monoclonal antibody 60 liposomal delivery 60 humanized monoclonal 60 biologic therapeutics 60 novel peptide 60 fusion enhancers 59 synthetic siRNA 59 Cumulase 59 CardioVascular BioTherapeutics 59 targeted antifolate 59 novel peptides 59 therapeutic monoclonal antibody 59 Quark Biotech Inc. 59 MediVas 59 humanized monoclonal antibodies 59 Phage Pharmaceuticals 59 thetreatment 59 small molecule modulators 59 Onconase 59 kidney urologic 59 engineered proteases 59 Sudhir Agrawal D.Phil 59 antitumoral 59 immatics 59 Factor VIIa 59 Delta opioid receptor 59 CB2 receptor 59 Receptos 59 targeted radiotherapeutic 59 novel immunotherapeutic 58 Monoclonal antibody 58 Angiocept 58 novel immunotherapies 58 ERYtech 58 Alfacell proprietary ribonuclease 58 recombinant antibodies 58 ActivX 58 tranilast 58 Affimed Therapeutics AG 58 A3 adenosine receptor 58 MTP inhibitor 58 hereditary emphysema 58 humanised monoclonal antibody 58 radionuclide therapy 58 Nereus Pharmaceuticals 58 subcutaneous immunoglobulin 58 Cerashield ™ 58 Arno Therapeutics 58 Curaxin 58 engineered RAP peptides 58 EndoTAG TM 58 Aviptadil 58 Fabry Disease 58 IMiDs R 57 Enkephalin 57 selective androgen receptor modulators 57 recombinant protein therapeutics 57 Receptors GPCRs 57 cardiometabolic disorders 57 cartilage regeneration 57 Genedata Expressionist ® 57 THR beta agonist 57 t2cure GmbH 57 Immunotherapeutic 57 siRNA therapeutics 57 MP4 molecule 57 cardio renal 57 Anticalins 57 Anticalins ® 57 Celator 57 adenosine A2A 57 Prodarsan ® 57 SMIP 57 Nanobodies ® 57 ESBA# 57 isoform selective 57 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 57 SoluBest 57 anti secretory 57 GMX# 57 Virdante 57 nanomedicines 57 Viprovex TM 57 NTDDS 57 lipidomics 57 IAP inhibitor 57 anticancer compounds 57 Friedreich Ataxia FRDA 57 AngioChem 57 JAK2 inhibitor 57 PET tracers 57 pharmaceuticals biopharmaceuticals 57 HQK 57 optimized siRNA 57 Oasmia 57 ProtAffin 57 Epitome Biosystems 57 Nasdaq HALO biopharmaceutical 57 depsipeptide 57 Nautilus Biotech 56 Protein Kinase C 56 Fibroblast Growth Factor Receptor 56 Omacetaxine 56 PROfusion 56 novel anticancer 56 immunotoxin 56 Regado Biosciences 56 passive immunotherapy products 56 morpholino 56 JAK inhibitors 56 tiapamil 56 antisense inhibitors 56 histone deacetylase HDAC 56 metabolite identification 56 uricase 56 Crop BioScience 56 histone deacetylase inhibitor 56 Myolimus 56 Civacir 56 epothilones 56 monoclonal antibodies mAbs 56 Fibrocell Science 56 TLR9 agonist 56 FOLOTYN ® 56 TransMolecular 56 theranostic 56 transfection reagents 56 MicuRx 56 VitiGam 56 RNAi therapeutic targeting 56 HCV protease inhibitors 56 Avila Therapeutics 56 biotherapeutic 56 proteins peptides 56 ProNAi 56 antisense therapeutics 56 drug conjugates ADCs 56 siRNA therapeutic 56 proteasome inhibitor 56 G Protein Coupled 56 immune modulatory 56 immunotoxins 56 HSP# inhibitors 56 ImmuneRegen BioSciences Inc. 56 metabolite profiling 56 RECOTHROM R 56 biased ligand 56 mimetics 56 defensin mimetic antibiotic 56 Locked Nucleic Acid LNA 56 metalloenzymes 56 IMiDs ® 56 Etubics 56 MORAb 56 predictive toxicology 56 Ambrx 56 molecular imaging radiopharmaceutical 56 enhance ApoA 56 microtubule inhibitor 56 asthma COPD Chronic 56 DiLA2 56 Novosom 56 mda 7 56 Intarcia 56 Trofex 56 oral antiviral 56 adrenergic regulation 55 Archexin 55 peptidic 55 peptidomimetic 55 KineMed 55 oncology immunology 55 Prodarsan R 55 immuno modulatory 55 selective immunoproteasome inhibitor 55 Cerashield 55 Squalamine 55 recombinant erythropoietin 55 YONDELIS 55 Supernus Pharmaceuticals 55 protein kinase inhibitors 55 Adenosine Therapeutics 55 antimitotic 55 vascular disrupting agents 55 Aerovance 55 Pervasis Therapeutics Inc. 55 Tarmogen 55 Dual Opioid TM 55 Novasome R 55 alkylating 55 novel therapeutic antibodies 55 vinca alkaloid 55 radiotherapeutic 55 ERYtech Pharma 55 Anidulafungin 55 cytotoxics 55 Quark Pharmaceuticals 55 herpes simplex viruses 55 glucokinase activator 55 direct thrombin inhibitors 55 Campath ® 55 nicotinic acetylcholine receptor 55 anticoagulant reversing agent 55 anticancer therapies 55 GelSite R polymer 55 Kirsten Drejer 55 synthetic peptides 55 Amarantus 55 MediGene focuses 55 genomic proteomic 55 GlycosBio 55 antisense oligonucleotides 55 indibulin 55 Scil Proteins 55 Inc. Nasdaq VIAP 55 Therion Biologics Corporation 55 siRNA compounds 55 CG# [003] 55 hypoxia activated prodrug 55 Cylene 55 investigational humanized monoclonal antibody 55 Preclinical studies suggest 55 investigational therapies 55 Myocet 55 small molecule activators 55 CureDM 55 ADME properties 55 GelSite polymer 55 IAP inhibitors 55 sodium thiosulfate STS 55 mertansine 55 peptibody 55 GCSF 55 prodrugs 55 ophthalmology oncology 55 LNP formulations 55 myeloproliferative disorders 55 Micromet BiTE 55 targeting PCSK9 55 ALN PCS 55 Acologix 55 Duncan Higgons 55 neuronal nicotinic receptors NNRs 55 potent antiproliferative 55 Pathway Inhibitor 55 immunoregulatory 55 M2 subunit 55 RNA antagonists 55 ACV1 55 Nasdaq MITI biopharmaceutical 55 Carigent 55 Protagen 55 fibrotic disorders 54 CYT# potent vascular disrupting 54 Personalized Immunotherapy 54 novel antiviral therapeutics 54 CXCR4 receptor 54 Anti angiogenic 54 anti amnesic 54 Hydra Biosciences 54 commercializing anti infective 54 treating neuropathic pain 54 PharmaNova 54 AMPK activators 54 Enhanze 54 cyclophilin inhibitors 54 therapeutic peptide 54 bioprocess engineering 54 pancreatic enzyme replacement 54 XmAb ™ 54 DNAi 54 MEK inhibitor 54 JAK inhibitor 54 novel antibody therapeutics 54 polyclonal antibody 54 NASDAQ BTRX pharmaceutical 54 topical formulations 54 OTCBB PWRM.OB 54 identify protein biomarkers 54 AEG# 54 preclinically 54 Vipin K. 54 systemic antifungal 54 taxane derivative 54 SECTA therapy 54 IMiDs ® compound 54 Nasdaq CGEN 54 HCV polymerase 54 NNR Therapeutics 54 Affibody ® molecules 54 Litx 54 ProFibrix 54 Ceflatonin 54 Caris MPI 54 FGFR 54 CCR9 antagonist 54 autologous cellular therapy 54 siRNAs targeting 54 Ostabolin C TM 54 Tß4 54 Adnectin 54 thalidomide Thalomid 54 Chemokine Therapeutics 54 histone deacetylase HDAC inhibitors 54 CEQ# 54 RECOTHROM ® 54 mTOR inhibition 54 Janus Kinase 54 Gamunex C 54 recombinant polyclonal antibodies 54 tkRNAi 54 Nanobody ® 54 PSN# [001] 54 ProLindac TM 54 Corixa Corporation 54 RNA antagonist 54 therapeutic mAbs 54 TLR8 54 ALN TTR# 54 EndoTAG 54 Wellstat 54 PDE# inhibitors 54 therapeutics 54 SuperAntibody 54 therapeutic radiopharmaceuticals 54 MAbs targeting 54 PDE4 inhibitor 54 polyketides 54 iPSC technology 54 Bacterin develops manufactures 54 Pepscan Therapeutics 54 ATL# [002] 54 DsiRNA 54 BioSilicon TM 54 Chemokine 54 polyclonal antibodies 54 Taligen Therapeutics 54 diagnostic biomarkers 54 drug conjugate 54 BHT DNA 54 potent anticancer 54 kallikrein 54 bioindustrial 54 neurology immunology 54 commercialize microRNA 54 BGC# 54 GelSite R 54 tPEMF tm 54 Carfilzomib 54 Dalbavancin 54 personalized immunotherapy 54 Avecia Biotechnology 54 Zenyaku Kogyo 54 Vaccinex 54 therapeutic proteins 54 NYSE Amex AEN 54 Cx# [002] 54 immuno inflammatory 54 Cytotoxic 54 Pervasis 54 recombinant protein 54 Fosphenytoin 54 Microbia 54 biosurgical 54 PEG SN# 54 stem cell therapeutics 54 cannabinor 54 intranasal delivery 54 iCeutica 53 TÎ ² 4 53 LEAD Therapeutics 53 anti CD3 antibody 53 receptor inhibitor 53 purinergic receptors P#X# 53 liposomal formulation 53 peptide antigens 53 Velcura 53 recombinant insulin 53 PORxin 53 elbion 53 Gendux 53 bioinnovation 53 Zemiva TM 53 rxRNA TM compounds 53 biotherapeutics 53 Panzem R 53 PROT biotechnology 53 small molecule thrombopoietin 53 echinocandin 53 Tobira Therapeutics 53 Onconova 53 Diatos 53 Panzem R NCD 53 Cerexa Inc. 53 bioprocesses 53 Japanese Encephalitis vaccine 53 monoclonal 53 embolotherapy 53 anti infective treatments 53 biomarker identification 53 Spiegelmer 53 myelofibrosis polycythemia vera 53 lipid nanoparticle 53 multitargeted 53 AFFiRiS 53 PAION AG ISIN 53 neuroactive 53 orthopedic biomaterials 53 Erimos 53 TLR9 agonists 53 ribonucleotide reductase clinically validated 53 siRNA conjugates 53 PI3K/mTOR 53 RNAi therapeutic targeting PCSK9 53 EHT AGN 53 mTOR inhibitors 53 OMP #M# 53 recombinant interferon 53 EGFR HER 53 preclinical efficacy 53 Cethrin R 53 anti CD3 53 Metallophile ™ Technology 53 Guanilib 53 Versartis 53 CytomX Therapeutics 53 fatty acid biosynthesis 53 Morria Biopharmaceuticals Plc 53 Diasome 53 ghrelin antagonist 53 nanocarriers 53 Conatus Pharmaceuticals 53 Neogenix 53 Regenerative medicine 53 antisense inhibitor 53 NovaBay Aganocide compounds 53 novel anti infective 53 selective inhibition 53 siRNA delivery 53 oligonucleotide therapeutics 53 monoclonal antibody mAb 53 Axiogenesis 53 Halozyme Therapeutics 53 Regulus Therapeutics 53 PI3K/Akt pathway inhibitor 53 epigenetic enzymes 53 Zacharon 53 ZEVALIN ® 53 Saegis Pharmaceuticals 53 Agios Pharmaceuticals 53 Scancell 53 adipose derived stem cell 53 OPi 53 OTCBB ARGA specialty 53 pharmacological chaperone 53 potently inhibit 53 nanobodies 53 Limerick BioPharma 53 DP VPA 53 Rebif ® 53 class mGluR5 inhibitor 53 Phase IIb clinical trials 53 Fc fusion protein 53 OXIGON TM 53 ligand TRAIL 53 immuno oncology 53 telomerase activator 53 Panzem 53 epigenetic therapies 53 immunomodulatory 53 MDRNA proprietary 53 mucosal vaccines 53 prostones 53 Aegis Therapeutics 53 STEDESA 53 Potelligent Technology 53 Aquinox 53 molecular chaperone regulation 53 diagnostic molecular imaging 53 autoimmune inflammatory 53 Maxy G# 53 IIB ActRIIB 53 oncolytic viruses 53 dSLIM 53 ENMD # 53 GLPG# 53 Vegenics 53 cyclophilin inhibitor 53 diagnostic biomarker 53 Cloretazine 53 selective orally bioavailable 53 vidofludimus 53 GeneICE 53 Inc. OTCBB LPTN 53 pan HDAC inhibitor 53 AKT inhibitor 53 Golimumab 53 CeNeRx 53 HDL Mimetic Peptide 53 immune modulating 53 Aplidin 53 Kapa Biosystems 53 NEUGENE R 53 biopharmaceuticals 53 immunodiagnostics 53 MGd 53 Locked Nucleic Acid 53 ISTO 53 autologous cell 52 sirtuin therapeutics 52 NuMimetic TM 52 doxorubicin HCl 52 CDP# 52 Archemix Corp. 52 RhuDex ® 52 Phylomer ® 52 dendrimer nanotechnology 52 dermatology therapies 52 glucagon receptor 52 recombinant factor VIIa 52 haematological cancers 52 bortezomib Velcade 52 macrocycles 52 antibiofilm 52 glycobiology 52 immunotherapy treatments 52 Locus Pharmaceuticals 52 aTyr Pharma 52 Aganocide ® 52 Epiphany Biosciences 52 HSP# inhibitor 52 Cutanea 52 sd rxRNA 52 SGLT2 inhibitors 52 mAbs 52 iobenguane 52 oral immunomodulatory 52 Chipscreen 52 Epitomics 52 biotherapies 52 radiolabeled monoclonal antibody 52 Charlesson 52 lipid nanoparticles 52 ImmunoCellular Therapeutics 52 P#X# antagonist 52 arGentis 52 systemic RNAi 52 Akebia Therapeutics 52 resorbable biomaterials 52 DPX Survivac 52 Corp. Nasdaq BSTC 52 topical dermatology 52 KuDOS 52 PKC# 52 Kazumi Shiosaki 52 Pichia pastoris 52 Kleanthis G. Xanthopoulos Ph.D. 52 radiation sensitizer 52 DepoVax 52 JAK2 inhibitors 52 molecularly targeted therapy 52 diarrhea predominant irritable 52 Avidex 52 antibiotic resistant bacterial infections 52 Cara Therapeutics 52 JAK3 52 Davanat 52 targeting CD# 52 psoriasis rheumatoid arthritis 52 Astex Therapeutics Limited 52 orally dosed 52 pregabalin Lyrica 52 Anavex #-# 52 Molecular Templates 52 Elixir Pharmaceuticals 52 RayBiotech 52 UltiMAb 52 OMRIX 52 Taligen 52 Nuron Biotech 52 Prolexys 52 acadesine 52 Idera Pharmaceuticals 52 Biosimilar 52 Pertuzumab 52 pharmacodynamic properties 52 topical anti infective 52 Corgentin 52 recombinant vaccines 52 Verdezyne 52 incyclinide 52 immunologic diseases 52 HepaLife 52 Interferon alpha 52 Syntonix 52 Topigen 52 Mersana Therapeutics 52 anticancer agents 52 PEGylated interferon 52 Hepregen 52 renin inhibitors 52 protein biochips 52 Fresenius Biotech 52 tyrosine kinase inhibitor 52 ToleroMune 52 oncology infectious diseases 52 PERCIVIA 52 outlicensed 52 eTag assays 52 peptide synthesis 52 Cetrorelix 52 Lixivaptan 52 Zelos Therapeutics 52 Thiakis 52 Cellzome 52 dasatinib Sprycel 52 BioThrax Anthrax Vaccine Adsorbed 52 allogeneic cell 52 Crofelemer 52 Azedra 52 dermal patch 52 Talabostat 52 Provectus Pharmaceuticals specializes 52 molecular biomarkers 52 biologic therapies 52 delta isoform 52 immunology oncology 52 Sangamo ZFP technology 52 Cloretazine R 52 Inc. dba Vitro 52 Bellicum 52 small molecule agonists 52 cellular immunotherapy 52 biopharm 52 Enzo Therapeutics 52 Robert J. Broeze 52 chemical entities NCEs 52 Zyngenia 52 immune modulators 52 Codon Devices 52 prokinetic 52 VisEn Medical 52 miRagen 52 Symphogen 52 Epothilones 52 Nanobody 52 polymerase inhibitors 52 regenerative medicine therapies 52 molecular biology genomics 52 Kiadis 52 ophthalmology dermatology 52 Neurimmune 52 ZARS Pharma 52 antisense oligonucleotide 52 NEUGENE 52 PER.C6 ® cell 52 HepDirect R 52 Neuradiab 52 Virulizin ® 52 BiTE 52 Aganocide 52 orally inhaled migraine 52 oral ghrelin agonist 52 AVI NEUGENE 52 PEGylation 52 Onalta 52 Bassil Dahiyat Ph.D. 52 NNRs 52 resolvin 52 OTCBB OHRP 52 biocatalysis 52 biosimilar versions 52 monoclonal antibodies 52 EyeGate 52 Cancidas 52 imexon 52 Stapled Peptide 52 Catalyst Biosciences 52 immunotherapeutics 52 ESBATech AG 52 GW# [003] 52 ALN TTR 52 PDGF receptor 52 p# inhibitor 52 HuCAL antibody 52 therapeutics diagnostics 52 LHRH antagonists 52 BioRexis 52 Pancreate 52 antineoplastic 52 humanized anti 52 BCR ABL inhibitors 52 Combivir Kivexa 52 monoclonals 52 telomerase inhibitor 52 romazarit 52 DispersinB R 52 AAV vector 52 Pimavanserin 52 miRNA therapeutics 52 PRT# 52 Therapeutic Proteins 51 Stem Cell Innovations 51 potency selectivity 51 tumor antigens 51 small molecule tyrosine 51 tumor vascular disrupting 51 Intarcia Therapeutics Inc. 51 immunotherapeutic 51 Biochronomer 51 cGMP manufacture 51 Camptothecin 51 diagnostics therapeutics 51 lipopeptide 51 biocatalysts 51 FoldRx Pharmaceuticals Inc. 51 Vidaza azacitidine 51 ocular inflammatory 51 peripherally acting 51 GIPET 51 membrane receptors 51 CytoFabTM 51 antigen sparing 51 hormone LHRH antagonist 51 monoclonal antibody therapies 51 NeurAxon Inc. 51 Dual Opioid 51 Tasimelteon 51 clinically differentiated 51 recombinant human 51 LentiVector technology 51 nonviral 51 Biotherapeutics 51 NASDAQ LIPD 51 antibacterial antiviral 51 KL4 surfactant 51 immunotherapeutic approaches 51 PDE# 51 Xanthus Pharmaceuticals Inc. 51 Phytomedics Inc. 51 XP #L 51 TPI ASM8 51 PORxin TM platforms 51 ZFP technology 51 MEK inhibitors 51 TG# [003] 51 Cenix BioScience 51 HuLuc# 51 peptide therapeutics 51 Smac mimetics 51 KaloBios Pharmaceuticals Inc. 51 cytoprotective 51 Aganocide TM 51 mitotic kinesins 51 ALGRX 51 BNC# 51 vitro ADME 51 cancer immunotherapies 51 ophthalmics 51 bio therapeutics 51 Mersana 51 Phytomedics 51 Monoclonal antibodies 51 antifibrotic 51 Optimata 51 EnzymeRx 51 BioLeap 51 Debiopharm SA 51 Decision Biomarkers 51 neuroscience autoimmune 51 Biolex 51 PI3K inhibitors 51 Milnacipran 51 pharmaceutical excipients 51 Oracea TM 51 Oncaspar 51 DOS# 51 Soliris eculizumab 51 biobetter 51 vaccines oncolytic virus 51 Tranzyme 51 SGLT Inhibitors 51 biomarker assays 51 COX Inhibiting Nitric Oxide 51 Nanobiotix 51 theranostics 51 Mesoblast Limited ASX MSB 51 Aegerion Pharmaceuticals 51 Oxagen 51 Adnectins 51 macrolide antibiotics 51 botanical therapeutics 51 infectious diseases autoimmune diseases 51 KAI Pharmaceuticals 51 antineoplastic agents 51 humanized antibody 51 Zybrestat 51 Chrysalin 51 protein therapeutics 51 monoclonal antibodies MAbs 51 Makefield Therapeutics 51 Bayhill Therapeutics 51 Bioral 51 neuro inflammatory 51 Abeome 51 OncoVEX 51 FzioMed 51 Prostacyclin 51 RNA therapeutics 51 Alligator Bioscience AB 51 CB1 antagonists 51 CyGenics 51 anti angiogenic drugs 51 Monoclonal Antibodies 51 Fleximer R 51 CYT# novel 51 INxin TM 51 Rasagiline 51 immunomodulators 51 rxRNA compounds 51 NASDAQ SCRX specialty 51 multiplex assay 51 TRV# [001] 51 potentiator 51 LEX System 51 histone methyltransferases HMTs 51 ddRNAi 51 LT NS# 51 Adherex Technologies 51 selective adenosine 51 immune modulation 51 Auspex Pharmaceuticals 51 ophthalmology dermatology cardiovascular disease 51 Romidepsin 51 antibody therapies 51 EyeGate Pharma 51 SPRIX ® 51 eniluracil 51 triphendiol 51 Nitec 51 interferon alpha IFN 51 VEGF receptor 51 Alocrest 51 Immunex Corporation 51 oxazolidinone 51 short interfering RNA 51 NeuroTrans TM 51 NeuroSolutions 51 SYGNIS 51 humanized antibodies 51 erythropoietic 51 Selexis 51 adrenal steroid hormones 51 Euroscreen 51 Adnexus 51 p# inhibitors 51 Idun Pharmaceuticals 51 Nitec Pharma 51 ImmunGene 51 Odyssey Thera 51 ORIDIS Biomed 51 antibody cytokine 51 immunomodulating 51 erlotinib Tarceva ® 51 Surface Logix 51 HTS assay 51 NP2 Enkephalin 51 Anchor Therapeutics 51 ELND-#/AZD-# 51 CTLA4 Ig 51 PORxin TM 51 RONDEL ™ 51 biologic 51 Biopump 51 deforolimus 51 investigational monoclonal antibody 51 Endotis 51 Anaphore 51 proteasome inhibitors 51 TLR agonists 51 Akesis Pharmaceuticals 51 Brussels THR 51 Aptamer 51 protein misfolding diseases 51 MorphoSys proprietary 51 immunoregulation 51 oral talactoferrin 51 GPR# agonists 51 Ecallantide 51 Curemark 51 faropenem 51 blood clot dissolving 51 lentiviral vectors 51 nanoparticle formulation 51 immunochemistry 51 Lipocine 51 protein tyrosine phosphatases 51 U1 Adaptors 51 pharmacogenetics 50 Blinatumomab 50 ZFNs clinical trials 50 TOPIGEN 50 antagomirs 50 Exosome 50 kinase inhibition 50 biomedicines 50 melanocortin receptors 50 Innate Pharma 50 Nasdaq PANC biotechnology 50 Cellerant 50 recombinant enzyme 50 molecularly targeted therapies 50 Curaxins 50 dermatological diseases 50 nebulized budesonide 50 isoform selective inhibitors 50 NexGenix 50 VentiRx 50 Amunix 50 carbohydrate polymers 50 molecular imaging radiopharmaceuticals 50 TLR8 agonist 50 vaccine GRNVAC1 50 BioSeek 50 noninfectious uveitis 50 sodium stibogluconate 50 MAXY VII 50 PRNewswire Sinovac Biotech 50 ganaxolone 50 vitro assay 50 oral prodrug 50 radiolabeled TM# 50 Abiraterone acetate 50 Isogenica 50 treat facial wrinkles 50 Selective Electrochemical Tumor Ablation 50 resorptive 50 Ophthotech 50 Sphingomab 50 PsychoGenics 50 Kreatech 50 EMD Biosciences Inc. 50 GammaCan 50 NewLink 50 anti CD# antibodies 50 New Chemical Entities 50 vivo potency 50 Cogane 50 UMN Pharma 50 druggable targets 50 GRN# 50 Synairgen 50 Antiangiogenic 50 InQ Biosciences 50 GnRH analogues 50 SomatoKine 50 Genedata 50 CMC Biologics 50 Inc. Nasdaq NLTX 50 Afferent Pharmaceuticals 50 RNAi compounds 50 Solulin 50 deacetylase inhibitors 50 Stratatech 50 siRNA sequences 50 angiogenesis inhibition 50 Exelixis compounds 50 mGluR5 antagonist 50 NOXXON 50 Crucell NV NASDAQ CRXL 50 Pepducin 50 antiinfective 50 SOLVAY PHARMACEUTICALS 50 NanoCrystal ® technology 50 molecular abnormalities 50 LibiGel ® 50 Ikaria Holdings Inc. 50 signal transduction inhibitors 50 Allylix 50 oncology therapeutics 50 van Duzer 50 HepDirect 50 TKM ApoB 50 radioprotective 50 ALung Technologies 50 BioFocus DPI Galapagos 50 Nasdaq CRXL 50 DNA methylation biomarkers